Data as of Q4 2025 (Dec 31, 2025)

Omada Health, Inc.

(OMDA)

Financial Statements · SEC EDGAR XBRL

Revenue
$260.2M
+53.2%
Net Income
-$12.8M
+72.9%
EPS
$-0.35
+94.3%
Gross Margin
65.7%
Op. Income
-$12.0M
+72.6%
FCF
$16.9M
+148.7%
Source: SEC EDGAR XBRL
Breakdown
Revenues
Revenues
Total Revenues
Cost of Revenues
Gross Profit
Operating Expenses & Income
Research & Development
Total Operating Expenses
Operating Income
Non-Operating Income/Expense
Other Non-Operating Income
Pre-Tax Income
Income Tax Expense
Net Income
EPS (Basic)
EPS (Diluted)
Shares Outstanding (Diluted)
FY 2025
FY 2024
FY 2023
$260.2M
$169.8M
$122.8M
$260.2M
$169.8M
$122.8M
$89.3M
$66.9M
$52.8M
$170.9M
$102.9M
$70.0M
$40.7M
$35.9M
$33.7M
$182.9M
$146.5M
$136.0M
-$12.0M
-$43.7M
-$66.0M
-$806K
-$3.5M
-$1.5M
-$12.8M
-$47.1M
-$67.5M
$0
$0
$0
-$12.8M
-$47.1M
-$67.5M
$-0.35
$-6.11
$-9.52
$-0.35
$-6.11
$-9.52
36.6M
7.7M
7.1M